Apresentação oral: nm23-h1, um gene supressor metastático

Notas do episódio

Autores: Gabriela Souza Chmieleski, Laura Sterian Ward, Natássia Elena Búfalo. Instituição: Universidade Estadual de Campinas (UNICAMP), Campinas - SP. DOI: https://doi.org/10.25248/anais.e8232.2021. Referências BOISSAN M, et al. The NDPK/NME superfamily: state of the art. Laboratory Investigation, 2018; 98: 164-174. KHAN I, et al. The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities. Oncotarget, 2018; 9: 10185-10202. LIU L, et al. Prognostic value and clinicopathologic significance of nm23 in various cancers: a systematic review and meta-analysis. International Journal of Surgery, 2018; 60: 257-265. MÁTYÁSI B, et al. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis. Pathology & Oncology Research, 2020; 26: 49-61. WANG Y, et al. NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties. Mol Cancer Res, 2019; 17:1665-1674. YU L, et al.The Multiple Regulation of Metastasis Suppressor NM23-H1 in Cancer. Life Sciences, 2021; 268: e118995